Stay updated on Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Added a top-level Locations section listing Illinois, Maryland, and Texas, and updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T20:19:23.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.2.0 updated to v3.3.2; no substantive changes to study content or layout detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:37:15.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The government operating-status notice has been removed; study details, eligibility requirements, and contact information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T06:53:41.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page shows the same content and layout in both screenshots, with no new information or removals.
    Difference
    0.4%
    Check dated 2025-11-03T20:45:44.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Updated operating-status notice and version to v3.2.0; removed v3.1.0.
    Difference
    2%
    Check dated 2025-10-06T05:13:24.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:00:17.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.